Neuroimaging  ||| S:0 E:13 ||| NNP
of  ||| S:13 E:16 ||| IN
Central  ||| S:16 E:24 ||| NNP
Sensitivity  ||| S:24 E:36 ||| NNP
Syndromes ||| S:36 E:45 ||| NNP
:  ||| S:45 E:47 ||| :
Key  ||| S:47 E:51 ||| NNP
Insights  ||| S:51 E:60 ||| NNPS
from  ||| S:60 E:65 ||| IN
the  ||| S:65 E:69 ||| DT
Scientific  ||| S:69 E:80 ||| NNP
Literature  ||| S:80 E:91 ||| NNP
Central  ||| S:91 E:99 ||| NNP
sensitivity  ||| S:99 E:111 ||| NN
syndromes  ||| S:111 E:121 ||| NNS
are  ||| S:121 E:125 ||| VBP
characterized  ||| S:125 E:139 ||| VBN
by  ||| S:139 E:142 ||| IN
distressing  ||| S:142 E:154 ||| JJ
symptoms ||| S:154 E:162 ||| NNS
,  ||| S:162 E:164 ||| ,
such  ||| S:164 E:169 ||| JJ
as  ||| S:169 E:172 ||| IN
pain  ||| S:172 E:177 ||| NN
and  ||| S:177 E:181 ||| CC
fatigue ||| S:181 E:188 ||| NN
,  ||| S:188 E:190 ||| ,
in  ||| S:190 E:193 ||| IN
the  ||| S:193 E:197 ||| DT
absence  ||| S:197 E:205 ||| NN
of  ||| S:205 E:208 ||| IN
clinically  ||| S:208 E:219 ||| JJ
obvious  ||| S:219 E:227 ||| JJ
pathology ||| S:227 E:236 ||| NN
.  ||| S:236 E:238 ||| .
The  ||| S:238 E:242 ||| DT
scientific  ||| S:242 E:253 ||| JJ
underpinnings  ||| S:253 E:267 ||| NN
of  ||| S:267 E:270 ||| IN
these  ||| S:270 E:276 ||| DT
disorders  ||| S:276 E:286 ||| NNS
are  ||| S:286 E:290 ||| VBP
not  ||| S:290 E:294 ||| RB
currently  ||| S:294 E:304 ||| RB
known ||| S:304 E:309 ||| VBN
.  ||| S:309 E:311 ||| .
Modern  ||| S:311 E:318 ||| JJ
neuroimaging  ||| S:318 E:331 ||| JJ
techniques  ||| S:331 E:342 ||| NNS
promise  ||| S:342 E:350 ||| VBP
new  ||| S:350 E:354 ||| JJ
insights  ||| S:354 E:363 ||| NNS
into  ||| S:363 E:368 ||| IN
mechanisms  ||| S:368 E:379 ||| NNS
mediating  ||| S:379 E:389 ||| VBP
these  ||| S:389 E:395 ||| DT
postulated  ||| S:395 E:406 ||| JJ
syndromes ||| S:406 E:415 ||| NN
.  ||| S:415 E:417 ||| .
We  ||| S:417 E:420 ||| PRP
review  ||| S:420 E:427 ||| VB
the  ||| S:427 E:431 ||| DT
results  ||| S:431 E:439 ||| NNS
of  ||| S:439 E:442 ||| IN
neuroimaging  ||| S:442 E:455 ||| VBG
applied  ||| S:455 E:463 ||| VBN
to  ||| S:463 E:466 ||| TO
five  ||| S:466 E:471 ||| CD
central  ||| S:471 E:479 ||| JJ
sensitivity  ||| S:479 E:491 ||| NN
syndromes ||| S:491 E:500 ||| NNS
:  ||| S:500 E:502 ||| :
fibromyalgia ||| S:502 E:514 ||| CD
,  ||| S:514 E:516 ||| ,
chronic  ||| S:516 E:524 ||| JJ
fatigue  ||| S:524 E:532 ||| JJ
syndrome ||| S:532 E:540 ||| NN
,  ||| S:540 E:542 ||| ,
irritable  ||| S:542 E:552 ||| JJ
bowel  ||| S:552 E:558 ||| JJ
syndrome ||| S:558 E:566 ||| NN
,  ||| S:566 E:568 ||| ,
temporomandibular  ||| S:568 E:586 ||| JJ
joint  ||| S:586 E:592 ||| JJ
disorder ||| S:592 E:600 ||| NN
,  ||| S:600 E:602 ||| ,
and  ||| S:602 E:606 ||| CC
vulvodynia  ||| S:606 E:617 ||| JJ
syndrome ||| S:617 E:625 ||| NN
.  ||| S:625 E:627 ||| .
Neuroimaging  ||| S:627 E:640 ||| JJ
studies  ||| S:640 E:648 ||| NNS
of  ||| S:648 E:651 ||| IN
basal  ||| S:651 E:657 ||| JJ
metabolism ||| S:657 E:667 ||| NN
,  ||| S:667 E:669 ||| ,
anatomic  ||| S:669 E:678 ||| JJ
constitution ||| S:678 E:690 ||| NN
,  ||| S:690 E:692 ||| ,
molecular  ||| S:692 E:702 ||| JJ
constituents ||| S:702 E:714 ||| NNS
,  ||| S:714 E:716 ||| ,
evoked  ||| S:716 E:723 ||| JJ
neural  ||| S:723 E:730 ||| JJ
activity ||| S:730 E:738 ||| NN
,  ||| S:738 E:740 ||| ,
and  ||| S:740 E:744 ||| CC
treatment  ||| S:744 E:754 ||| NN
effect  ||| S:754 E:761 ||| NN
are  ||| S:761 E:765 ||| VBP
compared  ||| S:765 E:774 ||| VBN
across  ||| S:774 E:781 ||| IN
all  ||| S:781 E:785 ||| DT
of  ||| S:785 E:788 ||| IN
these  ||| S:788 E:794 ||| DT
syndromes ||| S:794 E:803 ||| NN
.  ||| S:803 E:805 ||| .
Evoked  ||| S:805 E:812 ||| FW
sensory  ||| S:812 E:820 ||| FW
paradigms  ||| S:820 E:830 ||| FW
reveal  ||| S:830 E:837 ||| FW
sensory  ||| S:837 E:845 ||| FW
augmentation  ||| S:845 E:858 ||| FW
to  ||| S:858 E:861 ||| TO
both  ||| S:861 E:866 ||| DT
painful  ||| S:866 E:874 ||| JJ
and  ||| S:874 E:878 ||| CC
non-painful  ||| S:878 E:890 ||| JJ
stimulation ||| S:890 E:901 ||| NN
.  ||| S:901 E:903 ||| .
This  ||| S:903 E:908 ||| DT
is  ||| S:908 E:911 ||| VBZ
a  ||| S:911 E:913 ||| DT
transformative  ||| S:913 E:928 ||| JJ
observation  ||| S:928 E:940 ||| NN
for  ||| S:940 E:944 ||| IN
these  ||| S:944 E:950 ||| DT
syndromes ||| S:950 E:959 ||| NN
,  ||| S:959 E:961 ||| ,
which  ||| S:961 E:967 ||| WDT
were  ||| S:967 E:972 ||| VBD
historically  ||| S:972 E:985 ||| RB
considered  ||| S:985 E:996 ||| VBN
to  ||| S:996 E:999 ||| TO
be  ||| S:999 E:1002 ||| VB
completely  ||| S:1002 E:1013 ||| RB
of  ||| S:1013 E:1016 ||| IN
hysterical  ||| S:1016 E:1027 ||| NN
or  ||| S:1027 E:1030 ||| CC
feigned  ||| S:1030 E:1038 ||| NN
in  ||| S:1038 E:1041 ||| IN
origin ||| S:1041 E:1047 ||| NN
.  ||| S:1047 E:1049 ||| .
However ||| S:1049 E:1056 ||| RB
,  ||| S:1056 E:1058 ||| ,
whether  ||| S:1058 E:1066 ||| IN
sensory  ||| S:1066 E:1074 ||| JJ
augmentation  ||| S:1074 E:1087 ||| NN
represents  ||| S:1087 E:1098 ||| VBZ
the  ||| S:1098 E:1102 ||| DT
cause  ||| S:1102 E:1108 ||| NN
of  ||| S:1108 E:1111 ||| IN
these  ||| S:1111 E:1117 ||| DT
syndromes ||| S:1117 E:1126 ||| NN
,  ||| S:1126 E:1128 ||| ,
a  ||| S:1128 E:1130 ||| DT
predisposing  ||| S:1130 E:1143 ||| JJ
factor ||| S:1143 E:1149 ||| NN
,  ||| S:1149 E:1151 ||| ,
an  ||| S:1151 E:1154 ||| DT
endophenotype ||| S:1154 E:1167 ||| NN
,  ||| S:1167 E:1169 ||| ,
or  ||| S:1169 E:1172 ||| CC
an  ||| S:1172 E:1175 ||| DT
epiphenomenon  ||| S:1175 E:1189 ||| JJ
cannot  ||| S:1189 E:1196 ||| NNS
be  ||| S:1196 E:1199 ||| VB
discerned  ||| S:1199 E:1209 ||| VBN
from  ||| S:1209 E:1214 ||| IN
the  ||| S:1214 E:1218 ||| DT
current  ||| S:1218 E:1226 ||| JJ
literature ||| S:1226 E:1236 ||| NN
.  ||| S:1236 E:1238 ||| .
Further ||| S:1238 E:1245 ||| RB
,  ||| S:1245 E:1247 ||| ,
the  ||| S:1247 E:1251 ||| DT
result  ||| S:1251 E:1258 ||| NN
from  ||| S:1258 E:1263 ||| IN
cross-sectional  ||| S:1263 E:1279 ||| JJ
neuroimaging  ||| S:1279 E:1292 ||| JJ
studies  ||| S:1292 E:1300 ||| NNS
of  ||| S:1300 E:1303 ||| IN
basal  ||| S:1303 E:1309 ||| JJ
activity ||| S:1309 E:1317 ||| NN
,  ||| S:1317 E:1319 ||| ,
anatomy ||| S:1319 E:1326 ||| NN
,  ||| S:1326 E:1328 ||| ,
and  ||| S:1328 E:1332 ||| CC
molecular  ||| S:1332 E:1342 ||| JJ
constituency  ||| S:1342 E:1355 ||| NNS
are  ||| S:1355 E:1359 ||| VBP
extremely  ||| S:1359 E:1369 ||| RB
heterogeneous  ||| S:1369 E:1383 ||| VBN
within  ||| S:1383 E:1390 ||| IN
and  ||| S:1390 E:1394 ||| CC
between  ||| S:1394 E:1402 ||| IN
the  ||| S:1402 E:1406 ||| DT
syndromes ||| S:1406 E:1415 ||| NN
.  ||| S:1415 E:1417 ||| .
A  ||| S:1417 E:1419 ||| DT
defining  ||| S:1419 E:1428 ||| JJ
neuroimaging  ||| S:1428 E:1441 ||| JJ
signature  ||| S:1441 E:1451 ||| NN
cannot  ||| S:1451 E:1458 ||| RB
be  ||| S:1458 E:1461 ||| VB
discerned  ||| S:1461 E:1471 ||| VBN
for  ||| S:1471 E:1475 ||| IN
any  ||| S:1475 E:1479 ||| DT
of  ||| S:1479 E:1482 ||| IN
the  ||| S:1482 E:1486 ||| DT
particular  ||| S:1486 E:1497 ||| JJ
syndromes  ||| S:1497 E:1507 ||| NN
or  ||| S:1507 E:1510 ||| CC
for  ||| S:1510 E:1514 ||| IN
an  ||| S:1514 E:1517 ||| DT
over-arching  ||| S:1517 E:1530 ||| JJ
central  ||| S:1530 E:1538 ||| JJ
sensitization  ||| S:1538 E:1552 ||| JJ
mechanism  ||| S:1552 E:1562 ||| NN
common  ||| S:1562 E:1569 ||| JJ
to  ||| S:1569 E:1572 ||| TO
all  ||| S:1572 E:1576 ||| DT
of  ||| S:1576 E:1579 ||| IN
the  ||| S:1579 E:1583 ||| DT
syndromes ||| S:1583 E:1592 ||| NN
.  ||| S:1592 E:1594 ||| .
Several  ||| S:1594 E:1602 ||| JJ
issues  ||| S:1602 E:1609 ||| NNS
confound  ||| S:1609 E:1618 ||| VBP
initial  ||| S:1618 E:1626 ||| JJ
attempts  ||| S:1626 E:1635 ||| NNS
to  ||| S:1635 E:1638 ||| TO
meaningfully  ||| S:1638 E:1651 ||| VB
measure  ||| S:1651 E:1659 ||| NN
treatment  ||| S:1659 E:1669 ||| NN
effects  ||| S:1669 E:1677 ||| NNS
in  ||| S:1677 E:1680 ||| IN
these  ||| S:1680 E:1686 ||| DT
syndromes ||| S:1686 E:1695 ||| NN
.  ||| S:1695 E:1697 ||| .
At  ||| S:1697 E:1700 ||| IN
this  ||| S:1700 E:1705 ||| DT
time ||| S:1705 E:1709 ||| NN
,  ||| S:1709 E:1711 ||| ,
the  ||| S:1711 E:1715 ||| DT
existence  ||| S:1715 E:1725 ||| NN
of  ||| S:1725 E:1728 ||| IN
central  ||| S:1728 E:1736 ||| JJ
sensitivity  ||| S:1736 E:1748 ||| NN
syndromes  ||| S:1748 E:1758 ||| NN
is  ||| S:1758 E:1761 ||| VBZ
based  ||| S:1761 E:1767 ||| VBN
more  ||| S:1767 E:1772 ||| JJR
soundly  ||| S:1772 E:1780 ||| NN
on  ||| S:1780 E:1783 ||| IN
clinical  ||| S:1783 E:1792 ||| JJ
and  ||| S:1792 E:1796 ||| CC
epidemiological  ||| S:1796 E:1812 ||| JJ
evidence ||| S:1812 E:1820 ||| NN
.  ||| S:1820 E:1822 ||| .
A  ||| S:1822 E:1824 ||| DT
coherent  ||| S:1824 E:1833 ||| JJ
picture  ||| S:1833 E:1841 ||| NN
of  ||| S:1841 E:1844 ||| IN
a  ||| S:1844 E:1846 ||| DT
central  ||| S:1846 E:1854 ||| JJ
sensitization  ||| S:1854 E:1868 ||| JJ
mechanism  ||| S:1868 E:1878 ||| NN
that  ||| S:1878 E:1883 ||| IN
bridges  ||| S:1883 E:1891 ||| NNS
across  ||| S:1891 E:1898 ||| IN
all  ||| S:1898 E:1902 ||| DT
of  ||| S:1902 E:1905 ||| IN
these  ||| S:1905 E:1911 ||| DT
syndromes  ||| S:1911 E:1921 ||| NN
does  ||| S:1921 E:1926 ||| VBZ
not  ||| S:1926 E:1930 ||| RB
emerge  ||| S:1930 E:1937 ||| VB
from  ||| S:1937 E:1942 ||| IN
the  ||| S:1942 E:1946 ||| DT
existing  ||| S:1946 E:1955 ||| JJ
scientific  ||| S:1955 E:1966 ||| JJ
evidence ||| S:1966 E:1974 ||| NN
.  ||| S:1974 E:1976 ||| .
